RU2583158C2 - Methyl 5-(arylcarbamoyl) -1-(benzyl and phenyl)-4-cinnamoyl-1h-pyrazole-3-carboxylates, exhibiting analgesic activity and synthesis method thereof - Google Patents
Methyl 5-(arylcarbamoyl) -1-(benzyl and phenyl)-4-cinnamoyl-1h-pyrazole-3-carboxylates, exhibiting analgesic activity and synthesis method thereof Download PDFInfo
- Publication number
- RU2583158C2 RU2583158C2 RU2014123249/04A RU2014123249A RU2583158C2 RU 2583158 C2 RU2583158 C2 RU 2583158C2 RU 2014123249/04 A RU2014123249/04 A RU 2014123249/04A RU 2014123249 A RU2014123249 A RU 2014123249A RU 2583158 C2 RU2583158 C2 RU 2583158C2
- Authority
- RU
- Russia
- Prior art keywords
- ph
- cinnamoyl
- ar
- 1h
- pyrazole
- Prior art date
Links
- 230000000202 analgesic Effects 0 abstract title 2
- 125000002496 methyl group Chemical group data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 [H]C([H])([H])* 0 abstract title 2
- 238000001308 synthesis method Methods 0 title 1
- 150000001875 compounds Chemical class 0 abstract 2
- 108010078762 Protein Precursors Proteins 0 abstract 1
- 102000014961 Protein Precursors Human genes 0 abstract 1
- 230000015572 biosynthetic process Effects 0 abstract 1
- 230000000694 effects Effects 0 abstract 1
- 125000000623 heterocyclic group Chemical group 0 abstract 1
- 239000002243 precursor Substances 0 abstract 1
- 238000005365 production Methods 0 abstract 1
- 150000003217 pyrazoles Chemical class 0 abstract 1
- 239000000126 substances Substances 0 abstract 1
- 238000003786 synthesis Methods 0 abstract 1
- 230000002194 synthesizing Effects 0 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Abstract
Description
The invention relates to the field of organic chemistry, namely to new individual compounds of the pyrazole class and to a process for their preparation, which can be used as starting materials for the synthesis of new heterocyclic systems and in pharmacology.
Known structural analogues of the claimed compounds are obtained by the recycling of 4,5-diaroyl-1H-pyrrole-2,3-dione under the action of monosubstituted hydrazines in absolute chloroform at room temperature for 15-20 minutes, followed by boiling in ethanol for 20-30 minutes 2- (1- (benzyl and phenyl) -5-aryl-3-aroyl-1H-pyrazol-4-yl) -2-oxoacetic acid N-arylamides are formed (Silaichev P.S., Kudrevatykh N.V., Maslivets A.N. // ZhORKh. 2010.V. 46, issue 10. P. 1540-1543):
The disadvantages of this method include the inability to obtain methyl 5- (arylcarbamoyl) -1- (benzyl and phenyl) -4-cinnamoyl-1H-pyrazole-3-carboxylates.
The objective of the invention is to develop a simple method for the synthesis of methyl 5- (arylcarbamoyl) -1- (benzyl and phenyl) -4-cinnamoyl-1H-pyrazole-3-carboxylates not described in the literature.
The task is carried out by the interaction of methyl 1-aryl-3-cinnamoyl-4,5-dioxo-4,5-dihydro-1H-pyrrole-2-carboxylates (Silaichev P.S., Filimonov V.O., Slepukhin P.A. ., Maslivets A.N. // ZhORKh. 2012.V. 48. S. 563-567) (Ia-c) with benzylhydrazine (IIa) and phenylhydrazine (IIb) in an inert polar aprotic solvent - 1,4-dioxane according to the scheme:
The process is carried out by keeping the reagent solution in absolute 1,4-dioxane at a temperature of 100-102 ° C for 20-30 minutes.
From the patent and technical literature were not identified methods for producing methyl 5- (arylcarbamoyl) -1- (benzyl and phenyl) -4-cinnamoyl-1H-pyrazole-3-carboxylates having similar characteristics with the claimed method, namely, the original products, solvents in which the reaction takes place, and the temperature range, on the basis of which we can conclude that the claimed technical solution meets the criteria of "novelty" and "inventive step".
The invention is illustrated by the following examples.
Example 1. Methyl 1-benzyl-5- (phenylcarbamoyl) -4-cinnamoyl-1H-pyrazole-3-caboxylate (IIIa).
To a solution of 1.0 mmol of compound (Ia) in 20 ml of absolute 1,4-dioxane was added a solution of 1 mmol of benzylhydrazine (IIa) in 5 ml of absolute 1,4-dioxane, boiled for 30 minutes, the solvent was distilled off, the residue was recrystallized from ethanol. Yield 83% mp. 168-170 ° C (ethanol). Compound (IIIa) C 28 H 23 N 3 O 4 .
Found,%: C 72.22; Η 4.95; N 9.00.
Calculated,%: C 72.25; Η 4.98; N 9.03.
Compound (IIIa) is a colorless crystalline substance, readily soluble in DMF and DMSO, sparingly soluble in ordinary organic solvents, insoluble in alkanes and water.
The IR spectrum of compound (IIIa), recorded as a paste in liquid paraffin, contains valence vibration bands of the amide ΝΗ group at 3253 cm -1 , the methoxycarbonyl group at 1733 cm -1 , the amide carbonyl group at 1675 cm -1 , the ketone carbonyl group and a double bond of the cinnamoyl substituent at 1648 and 1620 cm -1 , as well as the amide II band at 1562 cm -1 .
In the 1H NMR spectrum of compound (IIIa) recorded in a solution in DMSO-d 6 , in addition to signals of protons of aromatic rings and related groups, there are a singlet of protons of a methoxycarbonyl substituent at 3.80 ppm, a singlet of a methylene group of a benzyl substituent at 5.56 ppm. , doublets of protons of the double bond of the cinnamoyl substituent at 7.26 and 7.53 ppm with spin-spin coupling constants characteristic of trans-substituted alkenes
Example 2. Methyl 1-phenyl-5- (phenylcarbamoyl) -4-cinnamoyl-1H-pyrazole-3-carboxylate (IIIb).
To a solution of 1.0 mmol of compound (Ia) in 20 ml of absolute 1,4-dioxane was added a solution of 1 mmol of phenylhydrazine (IIb) in 5 ml of absolute 1,4-dioxane, boiled for 30 minutes, the solvent was distilled off, the residue was recrystallized from ethanol. Yield 80%, mp. 209-210 ° C (ethanol). Compound (IIIb) C 27 H 21 N 3 O 4 .
Found,%: C 71.80; Η 4.66; N, 9.27.
Calculated,%: C 71.83; Η 4.69; N 9.31.
Compound (IIIb) is a colorless crystalline substance, readily soluble in DMF and DMSO, sparingly soluble in ordinary organic solvents, insoluble in alkanes and water.
The IR spectrum of compound (IIIb), recorded as a paste in liquid paraffin, contains stretching vibrations of the amide ΝΗ group at 3281 cm -1 , the methoxycarbonyl group at 1728 cm -1 , the amide carbonyl group at 1684 cm -1 , the ketone carbonyl group and a double bond of the cinnamoyl substituent at 1649 and 1621 cm -1 , as well as the strip "amide II" at 1558 cm -1 .
In the 1H NMR spectrum of compound (IIIb) recorded in a solution in DMSO-d 6 , in addition to signals of protons of aromatic rings and related groups, there are a singlet of protons of a methoxycarbonyl substituent at 3.86 ppm, doublets of protons of a double bond of a cinnamoyl substituent at 7.29 and 7.61 m .d. with spin-spin coupling constants characteristic of Airais-substituted alkenes
Compounds (IIIc-e) were synthesized in a similar manner.
The proposed method is simple to implement, one-step and allows to obtain methyl 5- (arylcarbamoyl) -1- (benzyl and phenyl) -4-cinnamoyl-1H-pyrazole-3-carboxylates (IIIa-e) with good yields, which are not described in the literature. will find application as starting materials for the synthesis of new heterocyclic systems and in pharmacology as potential medicines.
Example 5. Pharmacological study of methyl 5- (arylcarbamoyl) -1- (benzyl and phenyl) -4-cinnamoyl-1H-pyrazole-3-carboxylates (IIIa-g, e), for the presence of analgesic activity.
Evaluation of the analgesic properties of compounds (IIIa-d, e) was studied on outbred mice weighing 18-22 grams by the method of thermal stimulation "hot plate" according to Eddy and Leimbach (Eddy NB, Leimbarh DJ Pharmacol and Exper. Gher. 1953., 385-393) . Metamizole sodium was used as a reference drug.
Studies have shown (see table.) That compounds (IIIa-d, e) have a pronounced analgesic activity at or above that of the comparison drug. Data on the pharmacological activity of analogues of the claimed compounds in the available literature are not available.
Claims (5)
where III, Ar = Ph, R = CH 2 Ph (a), Ph (b); Ar = C 6 H 4 Me-4, R = CH 2 Ph (c), Ph
(g); Ar = C 6 H 4 OMe-4, R = CH 2 Ph (d), Ph (e).
where III, Ar = Ph, R = CH 2 Ph (a), Ph (b); Ar = C 6 H 4 Me-4, R = CH 2 Ph (c), Ph
(g); Ar = C 6 H 4 OMe-4, R = CH 2 Ph (d), Ph (e) possessing analgesic activity.
where III, Ar = Ph, R = CH 2 Ph (a), Ph (b); Ar = C 6 H 4 Me-4, R = CH 2 Ph (c), Ph
(g); Ar = C 6 H 4 OMe-4, R = CH 2 Ph (d), Ph (e),
characterized in that methyl 1-aryl-3-cinnamoyl-4,5-dioxo-4,5-dihydro-1H-pyrrole-2-carboxylates (Ia-b) of the formula
where I, Ar = Ph (a), C 6 H 4 Me-4 (b); Ar = C 6 H 4 OMe-4 (c),
subjected to interaction with benzylhydrazine (IIa) or phenylhydrazine (IIb) in an inert polar aprotic solvent, 1,4-dioxane, at a temperature of 100-102 ° C for 20-30 minutes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2014123249/04A RU2583158C2 (en) | 2014-06-06 | 2014-06-06 | Methyl 5-(arylcarbamoyl) -1-(benzyl and phenyl)-4-cinnamoyl-1h-pyrazole-3-carboxylates, exhibiting analgesic activity and synthesis method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2014123249/04A RU2583158C2 (en) | 2014-06-06 | 2014-06-06 | Methyl 5-(arylcarbamoyl) -1-(benzyl and phenyl)-4-cinnamoyl-1h-pyrazole-3-carboxylates, exhibiting analgesic activity and synthesis method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2014123249A RU2014123249A (en) | 2015-12-20 |
| RU2583158C2 true RU2583158C2 (en) | 2016-05-10 |
Family
ID=54871073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2014123249/04A RU2583158C2 (en) | 2014-06-06 | 2014-06-06 | Methyl 5-(arylcarbamoyl) -1-(benzyl and phenyl)-4-cinnamoyl-1h-pyrazole-3-carboxylates, exhibiting analgesic activity and synthesis method thereof |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2583158C2 (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2342365C2 (en) * | 2003-05-01 | 2008-12-27 | Бристол-Маерс Сквибб Компани | Arylsubstituted pyrazolamides as kinases inhibitors |
-
2014
- 2014-06-06 RU RU2014123249/04A patent/RU2583158C2/en not_active IP Right Cessation
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2342365C2 (en) * | 2003-05-01 | 2008-12-27 | Бристол-Маерс Сквибб Компани | Arylsubstituted pyrazolamides as kinases inhibitors |
Non-Patent Citations (1)
Also Published As
| Publication number | Publication date |
|---|---|
| RU2014123249A (en) | 2015-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2647853C2 (en) | Methods for producing certain 2-(pyridine-3-yl)thiazoles | |
| EP2308848A1 (en) | Quinoline-derived amide modulators of vanilloid VR1 receptor | |
| Liu et al. | Synthesis, dimeric crystal structure, and fungicidal activity of 1-(4-methylphenyl)-2-(5-((3, 5-dimethyl-1H-pyrazol-1-yl) methyl)-4-phenyl-4H-1, 2, 4-triazol-3-ylthio) ethanone | |
| CZ20022244A3 (en) | Trifluoromethyl pyrrolecarboxamides and trifluoromethyl pyrrolethioamides, process of their preparation and microbicidal preparation containing thereof | |
| EP0266558A2 (en) | 5-Alkylbenzimidazoles, process for their preparation and medicaments containing them | |
| Zhang et al. | Ag-containing all-carbon 1, 3-dipoles: generation and formal cycloaddition for furo [3, 2-b]-β/γ-lactams | |
| CN101466671A (en) | Novel microbiocides | |
| AU2006253842A1 (en) | Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation | |
| Attanasi et al. | Copper (II)/Copper (I)-Catalyzed Aza-Michael Addition/Click Reaction of in Situ Generated α-Azidohydrazones: Synthesis of Novel Pyrazolone− Triazole Framework | |
| Liu et al. | Microwave-assisted synthesis of novel fluorinated 1, 2, 4-triazole derivatives, and study of their biological activity | |
| Mansfield et al. | A robust and modular synthesis of ynamides | |
| Raap | Amination of tetrazoles with hydroxylamine-O-sulfonic acid: 1-and 2-aminotetrazoles | |
| Brahmachari et al. | Facile and one-pot access of 3, 3-bis (indol-3-yl) indolin-2-ones and 2, 2-bis (indol-3-yl) acenaphthylen-1 (2 H)-one derivatives via an eco-friendly pseudo-multicomponent reaction at room temperature using sulfamic acid as an organo-catalyst | |
| Hu et al. | From propargylamides to oxazole derivatives: NIS-mediated cyclization and further oxidation by dioxygen | |
| US2689853A (en) | Certain i | |
| CA1247101A (en) | 5-alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-one compounds, intermediates and methods for their preparation, and pharmaceutical compositions containing them | |
| DK2582694T3 (en) | Method of producing tetrazol-substituted anthranilsyrediamidderivater and new crystalline modification of these derivatives | |
| Mohareb et al. | Hydrazide-hydrazones in the synthesis of 1, 3, 4-oxadiazine, 1, 2, 4-triazine and pyrazole derivatives with anti-tumor activities | |
| Li et al. | Rhodium-Catalyzed Addition–Cyclization of Hydrazines with Alkynes: Pyrazole Synthesis via Unexpected C–N Bond Cleavage | |
| AU2003253776A1 (en) | Cck-1 receptor modulators | |
| Yang et al. | Pd/Cu-catalyzed cascade Sonogashira coupling/cyclization reactions to highly substituted 3-formyl furans | |
| Ding et al. | Visible-light photocatalytic aerobic annulation for the green synthesis of pyrazoles | |
| Beyhan et al. | Synthesis and anticonvulsant activity of some 2-pyrazolines derived from chalcones | |
| KR20180101342A (en) | 4 - ((6- (2- (2,4-difluorophenyl) -1,1-difluoro-2-hydroxy- ) Propyl) pyridin-3-yl) oxy) benzonitrile and the preparation method | |
| Levai et al. | Synthesis of 3‐aryl‐5‐styryl‐2‐pyrazolines by the reaction of (E, E)‐cinnamylideneacetophenones with hydrazines and their oxidation into pyrazoles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20160607 |